Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/24677
Title: Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
Authors: Wierda, W
Kipps, T
Mayer, J
Stilgenbauer, S
Williams, CD
Hellmann, A
Robak, T
Furman, RR
Hillmen, P
Trneny, M
Dyer, MJS
Padmanabhan, S
Piotrowska, M
Kozak, T
Chan, G
Davis, R
Losic, N
Wilms, J
Russell, C
Osterborg, A
First Published: 1-Dec-2009
Publisher: CIG MEDIA GROUP, LP
Citation: CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (6), pp. E36-E36
DOI Link: 10.3816/CLM.2009.n.098
ISSN: 1557-9190
Links: http://hdl.handle.net/2381/24677
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.